Keywords: gsk, overcomes, augmentin, woes, posts, strong, sales
GSK overcomes Augmentin woes, posts strong sales and earnings in 1st quarter
Article | 05 May 2003
Europe's leading drugmaker, GlaxoSmithKline, has reported results aheadof expectations for the first quarter of 2003, as the firm benefited from cost-cutting ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
